|By PR Newswire||
|March 18, 2014 05:00 PM EDT||
DUBLIN, March 18, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/rs4wkl/china) has announced the addition of the "Concise Analysis of the Chinese Pharmaceutical Equipment Industry" report to their offering.
After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total profit of China's pharmaceutical equipment industry both have increased significantly, and the revenue achieved a year-on-year growth rate of 51.5%, 28.2% and 26% in 2010-2012 respectively.
However, restricted by the actual progress of new GMP certification and market capacity, the revenue growth of China's pharmaceutical equipment industry will slow down in 2013-2016, probably at an annual average growth rate of 20% or so, and the revenue is expected to reach RMB 53.22 billion in 2016.
Due to a wide range of pharmaceutical equipment product categories and a customized business model generally adopted by enterprises, there is no one or a few pharmaceutical equipment companies capable of controlling the entire market, the industry concentration is low, the majority of enterprises are small and medium-sized, and the market concentration is low (20%=CR8<40%).
Shinva Medical Instrument Co., Ltd. is a leading sterilization equipment company in China. Its revenue from medical equipment (including pharmaceutical equipment) was RMB 2.408 billion in 2012 and RMB 1.524 billion in the first half of 2013. According to the statistics of China Association for Pharmaceutical Equipment, Shinva sold 10,048 units of sterilization equipment in 2012 and 7,873 units in the first 11 months of 2013, accounting for 86.8% and 84.3% of the total sales volume respectively.
Shanghai Tofflon Science and Technology Co., Ltd. is the leader in China's freeze-drying system industry, and realized revenue of RMB 822 million in 2012, accounting for 3.3% of China's pharmaceutical equipment market; in China's freeze-dryer market, it occupied a market share of 50-60% by sales in 2012 and 2013.
Truking Technology Limited is a major supplier of liquid injection pharmaceutical equipment in China, its revenue in 2012 was RMB 589 million, occupying 2.3% of China's pharmaceutical equipment market; in 2012, it accounted for 29.2% of the infusion device market by sales volume. Hunan China Sun Pharmaceutical Machinery Co., Ltd. is also an important supplier of injection pharmaceutical equipment in China, its revenue in 2012 was RMB 365 million, holding 1.4% of China's pharmaceutical equipment market; in 2012, it contributed 19.1% of the sales volume in the infusion device market.
Key Topics Covered:
1. Overview of Pharmaceutical Equipment Industry
2. Overview of Chinese Pharmaceutical Equipment Industry
3. Development Environment of China Pharmaceutical Equipment Industry
4. China Pharmaceutical Equipment Industry Development Forecast
5. Major Enterprises of China Pharmaceutical Equipment Industry
- Beijing Double-Crane Pharmaceutical Equipment
- Harbin Nano Pharmaceutical & Chemical Equipment
- Hunan China Sun Pharmaceutical Machinery
- Jiangsu Saideli Pharmaceutical Machine
- Shanghai Far-East Pharmaceutical Machinery
- Shanghai Tofflon Science and Technology
- Shinva Medical Instrument
- Truking Technology Limited
- Wenzhou Yaguang Machinery Manufacturing
- Zhejiang Hualian Pharmaceutical Machinery
For more information visit http://www.researchandmarkets.com/research/rs4wkl/china
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
Sep. 28, 2016 09:15 PM EDT Reads: 328
Sep. 28, 2016 08:30 PM EDT Reads: 433
Sep. 28, 2016 08:30 PM EDT Reads: 1,711
Sep. 28, 2016 08:15 PM EDT Reads: 323
Sep. 28, 2016 07:00 PM EDT Reads: 1,626
Sep. 28, 2016 06:45 PM EDT Reads: 4,150
Sep. 28, 2016 06:30 PM EDT Reads: 3,110
Sep. 28, 2016 06:15 PM EDT Reads: 286
Sep. 28, 2016 06:00 PM EDT Reads: 1,773
Sep. 28, 2016 05:15 PM EDT Reads: 247
Sep. 28, 2016 05:15 PM EDT Reads: 248
Sep. 28, 2016 05:00 PM EDT Reads: 1,724
Sep. 28, 2016 04:30 PM EDT Reads: 2,814
Creating replica copies to tolerate a certain number of failures is easy, but very expensive at cloud-scale. Conventional RAID has lower overhead, but it is limited in the number of failures it can tolerate. And the management is like herding cats (overseeing capacity, rebuilds, migrations, and degraded performance). Download Slide Deck: ▸ Here In his general session at 18th Cloud Expo, Scott Cleland, Senior Director of Product Marketing for the HGST Cloud Infrastructure Business Unit, discusse...
Sep. 28, 2016 04:15 PM EDT Reads: 2,438
Sep. 28, 2016 04:15 PM EDT Reads: 1,879